US FDA Support For Cosmetic Allergen Labeling Has Foundation In Consumers' ‘Right To Know’

28 Oct 2021

• By Lauren Nardella

Office of Cosmetics and Colors Linda Katz emphasizes FDA sees allergen labeling as a public health issue. While many allergic reactions are minor, “consumers who are extremely or exclusively sensitive to a particular ingredient should have a right to know.”

As the US Food and Drug Administration completes its research into cosmetic allergens, an area of “tremendous concern,” it is encouraging voluntary compliance for labeling that aligns with what is mandatory for products sold in the European Union.

Linda Katz, director of the FDA Office of Cosmetics and Colors, emphasized that the agency sees allergen labeling as a...